In vitro evaluation of intracellular activity of antibiotics against non-typhoid Salmonella (Q40944909)

25 September 2017

title

In vitro evaluation of intracellular activity of antibiotics against non-typhoid Salmonella (English)

1 reference

25 September 2017

0 references

Chiu CH

1 reference

25 September 2017

Lin TY

series ordinal

1 reference

25 September 2017

Ou JT

series ordinal

1 reference

25 September 2017

publication date

1 June 1999

1 reference

International Journal of Antimicrobial Agents

25 September 2017

published in

1 reference

25 September 2017

1 reference

25 September 2017

1 reference

25 September 2017

page(s)

47-52

1 reference

A controlled trial comparing sulfametboxazole-trimethoprim, ampicillin, and no therapy in the treatment of salmonella gastroenteritis in children

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

Treatment of Typhoid Fever and Other Systemic Salmonelloses with Cefotaxime, Ceftriaxone, Cefoperazone, and Other Newer Cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

Intracellular activity of azithromycin against bacterial enteric pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

Strain differences in expression of virulence by the 90 kilobase pair virulence plasmid of Salmonella serovar Typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

Antibiotic entry into human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

Intracellular organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

Intraphagocytic activity of erythromycin, roxithromycin and azithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

Efficacy of azithromycin for typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900038-2

7 January 2021

10.1016/S0924-8579(99)00038-2

Identifiers

DOI

1 reference

25 September 2017

1 reference